E-cigarettes Show Lower Cell Toxicity Than Traditional Cigarettes

Nov.18.2022
E-cigarettes Show Lower Cell Toxicity Than Traditional Cigarettes
The study found that e-cigarettes have less impact on cells than traditional cigarettes, using extracellular vesicle proteomics for analysis.

On November 5th, a research team led by Associate Researcher Yu Suhong from Fuzhou University published a paper in the authoritative global toxicology journal, "Toxicology in Vitro," which found that the impact of electronic cigarettes on cells is significantly lower than that of traditional cigarettes.


The study used exosome proteomics for the first time to compare the effects of electronic cigarettes and traditional cigarettes on human bronchial epithelial cells. Exosomes are small membrane vesicles containing complex RNA and proteins, which can be used as biomarkers for early diagnosis and prognosis evaluation of diseases such as cancer.


Research data shows that cigarette tar leads to more differences in protein expression of extracellular vesicles within cells, and these are significantly enriched in cancer signaling pathways. Meanwhile, differences caused by e-cigarettes are less pronounced. Toxicology studies have also found that cigarette tar significantly inhibits cell activity, while e-cigarette tar did not produce similar negative effects, indicating that the cellular toxicity of e-cigarettes is relatively low.


The paper was published in the toxicology SCI journal, "In Vivo Toxicology.


In recent years, several studies have found that electronic cigarettes may be a form of harm reduction product.


In 2021, the Pennsylvania State University College of Medicine published a paper in Cancer stating that e-cigarettes could be effective tools for quitting smoking and also decrease the production of carcinogens in smokers' lungs. In 2022, an editorial in Nature suggested that for patients with gum health concerns, e-cigarettes may be a safer nicotine substitute and could reduce the risk of oral cancer.


According to Associate Researcher Yu Suhong, this study is the first to systematically analyze the safety of cigarettes and e-cigarettes starting from extracellular vesicles, filling a gap in the relevant field.


According to research findings, electronic cigarettes are less harmful than traditional cigarettes and may be a reduced-harm product," said Yu Suhong. However, electronic cigarettes are not entirely safe and should not be used by non-smokers.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Thailand’s health minister rejects vaping as a smoking cessation alternative
Thailand’s health minister rejects vaping as a smoking cessation alternative
Thailand’s Public Health Minister Phatthana Phromphat has reaffirmed that the government does not support cigarettes or e-cigarettes in any form and opposes the use of e-cigarettes as a substitute for smoking cessation.
Dec.17 by 2FIRSTS.ai
2Firsts Interview | Bengt Wiberg: Why the Oral Health Risks of Nicotine Pouches Merit Further Study
2Firsts Interview | Bengt Wiberg: Why the Oral Health Risks of Nicotine Pouches Merit Further Study
As nicotine pouches gain global traction as a lower-risk alternative to smoking, questions are emerging about their potential oral health effects. In a 2Firsts interview, Stingfree AB founder Bengt Wiberg discusses why gum irritation and oral lesions warrant closer scrutiny within the broader framework of tobacco harm reduction.
Jan.06
Imperial Brands’ blu adds “Creamy Tobacco” flavour, rolling out across device kits and pod products
Imperial Brands’ blu adds “Creamy Tobacco” flavour, rolling out across device kits and pod products
Imperial Brands’ vaping brand blu has outlined its flavour roadmap for 2026 on its official website, adding a new “Creamy Tobacco” flavour that has been rolled out across the rechargeable blu bar kit and its compatible blu kit pods. The brand describes the flavour as offering a more velvety tobacco taste.
Dec.19
Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
In this in-depth commentary for 2Firsts, Alan Zhao examines what Altria’s on! PLUS authorization really signals about FDA PMTA enforcement. Beyond the headline approval, FDA’s language, process design and product choices offer rare insight into how nicotine pouch regulation is taking shape—and what it means for industry compliance, in one of the earliest expert reads of the decision.
Regulations
Dec.20 by 2Firsts Perspectives
U.S. Nicotine Pouch Sales Surge, Forcing Convenience Stores to Rethink Backbar Layouts
U.S. Nicotine Pouch Sales Surge, Forcing Convenience Stores to Rethink Backbar Layouts
U.S. convenience stores are restructuring backbar displays as nicotine pouches and other modern oral products gain space amid regulatory and product-mix shifts. The New York Association of Convenience Stores reports nicotine pouch sales are up over 40% this year, while some chains are trimming cigarette facings and testing zero-nicotine and herbal alternatives.
Dec.04 by 2FIRSTS.ai
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
British American Tobacco (BAT) reaffirmed its 2026 guidance while announcing a £1.3 billion (approximately USD 1.65 billion) share buyback for FY26. The company expects around 2% growth in revenue and adjusted profit from operations for FY25. Accelerating New Category growth, driven by Velo Plus and improving U.S. Vuse performance, is expected to deliver double-digit H2 revenue growth.
Dec.09 by 2FIRSTS.ai